Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
<h4>Background</h4>Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo tha...
Enregistré dans:
Auteurs principaux: | Alfonso Baldi, Maria Teresa Piccolo, Maria Rosaria Boccellino, Aldo Donizetti, Irene Cardillo, Raffaele La Porta, Lucio Quagliuolo, Enrico P Spugnini, Francesca Cordero, Gennaro Citro, Massimo Menegozzo, Raffaele A Calogero, Stefania Crispi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/acef1d49b26b4ff8a14a7824a0ed1cc5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
par: Camillo Porta, et autres
Publié: (2008) -
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
par: Zhen Zeng, et autres
Publié: (2018) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
par: Sara Ricciardi, et autres
Publié: (2021) -
Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations
par: Zhao L, et autres
Publié: (2020) -
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
par: Nobukazu Fujimoto, et autres
Publié: (2021)